Survey of Ophthalmology
Volume 54, Issue 6 , Pages 697-704, November 2009

Characteristics of Orbital Multiple Myeloma: A Case Report and Literature Review

Oculoplastics Service, Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, Wisconsin, USA

published online 26 August 2009.

Stefan Seregard and Milton Boniuk, Editors

Abstract 

Multiple myeloma is a plasma cell malignancy that destroys skeletal, renal, and neurological function. Orbital involvement is rare, but has been considered an initial presentation for the malignancy. Furthermore, an association between the subtype of multiple myeloma and the likelihood of orbital infiltration has been suggested. We present a case of an orbital mass that was a recurrence of multiple myeloma. A literature search was performed to evaluate the presentation characteristics of orbital multiple myeloma, plasmacytoma and primary (or solitary) extramedullary plasmacytoma. Past reports were analyzed for age, sex, symptoms at presentation, time from symptom onset to presentation, prior diagnosis before presentation for orbital symptoms, radiological characteristics, immunoglobulin subtype, and survival times. Less than half of published cases had orbital multiple myeloma as the primary presentation. Proptosis is the major presenting sign of orbital multiple myeloma, and radiological evaluation shows that the majority of masses originate in the superotemporal quadrant. The dominant immunoglobulin subtype was IgG.

Key words: eye, multiple myeloma, orbit, plasmacytoma, primary/solitary extramedullary plasmacytoma

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 The authors reported no proprietary or commercial interest in any product mentioned or concept discussed in this article. Supported in part by an unrestricted grant from Research to Prevent Blindness Inc., NY, NY.

PII: S0039-6257(09)00117-9

doi:10.1016/j.survophthal.2009.04.012

Survey of Ophthalmology
Volume 54, Issue 6 , Pages 697-704, November 2009